University of Calgary scientists receive $400k for COVID research

Snaps for Calgary’s medical community! This has actually become our favourite place to look for positivity, as of late. Today, we’re stoked to report that two University of Calgary scientists have actually received funding to study COVID-19 on the chemical and molecular level, in hopes of developing a medication that is able to combat severe symptoms.

In total, Dr. Kenneth Ng, from the University of Calgary Department of Biological Sciences, and Dr. Chang-Chun Ling, from the Department of
Chemistry, have received just over $400,000. This will make a huge difference in the quality and depth of their research.

Thanks to the funding given to them by the Canadian Institutes of Health Research, Dr. Ng and Dr. Chang-Chun Ling can begin breaking down the molecular structure of a crucial COVID-19 enzyme. After this is done, they plan to copy its genetic material in order to find the small chemical compound that binds the enzyme.

Related Posts:
Calgary’s forecast calls for 19 degrees and sunny days next week!
Musicians bring ‘Canada Together’ in 5-day concert series for charity

Ultimately, the goal is that they’ll be able to develop a drug that will prevent patients from having to stay in the hospital for such a long period of time with coronavirus symptoms.

We’re by no means, a bunch of scientists, but that sounds promising!

There isn’t currently a drug or antibiotic that can be used to successfully relieve the violent symptoms caused by the novel virus, so we’re rooting for them!

Congrats docs!